Karger André, Kisić Anna-Maria, Quente Caterina, Klett Maike K, Schäfer Ralf, Sabel Michael, Rapp Marion
Clinical Institute of Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.
Psychooncology. 2025 Jan;34(1):e70064. doi: 10.1002/pon.70064.
Malignant brain tumors are associated with debilitating symptoms and a poor prognosis, resulting in high psychological distress for patients and caregivers. There is a lack of longitudinal studies investigating psychological distress in this group. This study evaluated fear of progression (FoP), anxiety and depression in patients and their caregivers in the 6 months following malignant brain tumor diagnosis.
This prospective, observational study assessed FoP (FoP-Q-SF[P]), anxiety and depression (HADS) at diagnosis (T0) and after three (T1) and 6 months (T2) in patients with malignant brain tumors (primary, secondary) and their caregivers. Multilevel analyses were used to examine changes over time and differences between patients and caregivers, while accounting for the interdependence in their distress values.
Seventy-one patients and 68 caregivers were included in the analysis. Throughout the study period, over 50% reported clinically relevant FoP, almost 50% reported clinically relevant anxiety, and over 30% reported relevant depression. Over all time points, caregivers reported significantly higher anxiety and depression than patients. Anxiety decreased between T0 and T2 in both groups. Exploratory analyses showed that female sex was associated with higher anxiety, and older age with higher depression. No significant predictors were identified for FoP.
A substantial number of patients and caregivers experience clinically relevant psychological distress in the 6 months following a malignant brain tumor diagnosis. Caregivers are particularly distressed, reporting higher anxiety and depression. Integrating psycho-oncological assessments and interventions for both patients and caregivers into clinical care is critical to address the psychological distress associated with malignant brain tumors.
恶性脑肿瘤会引发使人衰弱的症状且预后较差,给患者及其照料者带来高度的心理困扰。目前缺乏针对该群体心理困扰的纵向研究。本研究评估了恶性脑肿瘤诊断后6个月内患者及其照料者的疾病进展恐惧(FoP)、焦虑和抑郁情况。
这项前瞻性观察性研究在恶性脑肿瘤(原发性、继发性)患者及其照料者确诊时(T0)、3个月后(T1)和6个月后(T2)评估了疾病进展恐惧(FoP-Q-SF[P])、焦虑和抑郁(医院焦虑抑郁量表)。采用多水平分析来检验随时间的变化以及患者与照料者之间的差异,同时考虑他们困扰值之间的相互依存关系。
71名患者和68名照料者纳入分析。在整个研究期间,超过50%的人报告有临床相关的疾病进展恐惧,近50%的人报告有临床相关的焦虑,超过30%的人报告有相关的抑郁。在所有时间点,照料者报告的焦虑和抑郁显著高于患者。两组在T0到T2之间焦虑均有所下降。探索性分析表明,女性与较高的焦虑相关,年龄较大与较高的抑郁相关。未发现疾病进展恐惧的显著预测因素。
大量患者及其照料者在恶性脑肿瘤诊断后的6个月内经历了临床相关的心理困扰。照料者尤其困扰,报告的焦虑和抑郁程度更高。将针对患者及其照料者的心理肿瘤学评估和干预纳入临床护理对于解决与恶性脑肿瘤相关的心理困扰至关重要。